Open original FDA record ↗Recall record
- FDA identifier
- Z-1672-2020
- Company in FDA record
- Qualigen Inc
- FDA record creation date
- Apr 6, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The chemiluminescent immunoassay has been noted to have higher than expected results which may result in inaccurate quantitative determinations of Sex Hormone Binding Globulin in human serum and plasma.
Source facts
- Action
- On October 31, 2019, a "Urgent: Product Recall" letter was sent to customer via E-Mail. In addition to informing consignees about the recall the customer notification asked consignees to take the following actions: 1. The firm will provide replacement kits at no cost as soon as they become available. 2. For any kits that have been purchased a refund can be requested in place of replacement kits. 3. As part of the product replacement process, please confirm that any remaining SHBG FastPacks/Kits of Lot Number 1908038-1P have been discarded on the form below. 4. The firm will call to confirm that you have received the letter and provide any additional details you may require. For questions, please contact System Support at systemsupport@qualigeninc.com.
- Initiated
- 2019-11-06
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-09-23
- Distribution
- US Nationwide distribution in the states of AL, AK, CA, HI, and TX.
- Recall number
- Z-1672-2020
- Recall status
- Terminated
- CDRH record ID
- 180150
- FDA record created
- 2020-04-06
- Recall event number
- 85134